Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF-MS spectra

被引:20
作者
Beyer, S
Walter, Y
Hellmann, J
Kramer, PJ
Kopp-Schneider, A
Kroeger, M [1 ]
Ittrich, C
机构
[1] Merck KGaA, Inst Toxicol, Darmstadt, Germany
[2] German Canc Res Ctr, D-6900 Heidelberg, Germany
关键词
SELDI-TOF-MS; toxicoproteomics; early predictive biomarker patterns; liver toxicity and carcinogenicity; linear mixed model;
D O I
10.1021/pr050279o
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A common animal model of chemical hepatocarcinogenesis was used to demonstrate the potential identification of carcinogenicity related protein signatures/biomarkers. Therefore, an animal study in which rats were treated with the known liver carcinogen N-nitrosomorpholine (NNM) or the corresponding vehicle was evaluated. Histopathological investigation as well as SELDI-TOF-MS analysis was performed. SELDI-TOF-MS is an affinity-based mass spectrometry method in which subsets of proteins from biological samples are selectively adsorbed to a chemically modified surface. The proteins are subsequently analyzed with respect to their mass-charge ratios (m/z) by a time of flight (TOF) mass spectrometry (MS) approach. As data preprocessing of SELDI-TOF-MS spectra is essential, baseline correction, normalization, peak detection, and alignment of raw spectra were performed using either the Ciphergen ProteinChip Software 3.1 or functions implemented in the library PROcess of the BioConductor Project. Baseline correction and normalization algorithms of both tools lead to comparable results, whereas results after peak detection and alignment steps differed. Variability between technical and biological replicates was investigated. A linear mixed model with factors experimental group and time point was applied for each protein peak, taking into account the different correlation structure of technical and biological replicates. Alternatively, only median intensity values of technical replicates were used. Results of both models were similar and correlated well with those of the histopathological evaluation of the study. In conclusion, statistical analyses lead to comparable results, whereas parameter settings for preprocessing proved to be crucial.
引用
收藏
页码:254 / 261
页数:8
相关论文
共 38 条
[21]   The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis [J].
Kennedy, S .
BIOMARKERS, 2002, 7 (04) :269-290
[22]  
LI Y, BIOCONDUCTOR VIGNETT
[23]   Importance of communication between producers and consumers of publicly available experimental data [J].
Liotta, LA ;
Lowenthal, M ;
Mehta, A ;
Conrads, TP ;
Veenstra, TD ;
Fishman, DA ;
Petricoin, EF .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (04) :310-314
[24]   High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures [J].
Lopez, MF ;
Mikulskis, A ;
Kuzdzal, S ;
Bennett, DA ;
Kelly, J ;
Golenko, E ;
DiCesare, J ;
Denoyer, E ;
Patton, WF ;
Ediger, R ;
Sapp, L ;
Ziegert, T ;
Lynch, C ;
Kramer, S ;
Whiteley, GR ;
Wall, MR ;
Mannion, DP ;
Della Cioppa, G ;
Rakitan, JS ;
Wolfe, GM .
CLINICAL CHEMISTRY, 2005, 51 (10) :1946-1954
[25]   Analysis of albumin-associated peptides and proteins from ovarian cancer patients [J].
Lowenthal, MS ;
Mehta, AI ;
Frogale, K ;
Bandle, RW ;
Araujo, RP ;
Hood, BL ;
Veenstra, TD ;
Conrads, TP ;
Goldsmith, P ;
Fishman, D ;
Petricoin, EF III ;
Liotta, LA .
CLINICAL CHEMISTRY, 2005, 51 (10) :1933-1945
[26]  
Merchant M, 2000, ELECTROPHORESIS, V21, P1164, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.3.CO
[27]  
2-S
[28]  
Moyses C., 1999, INT J PHARM MED, V13, P197
[29]   SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer [J].
Petricoin, EF ;
Liotta, LA .
CURRENT OPINION IN BIOTECHNOLOGY, 2004, 15 (01) :24-30
[30]   Use of proteomic patterns in serum to identify ovarian cancer [J].
Petricoin, EF ;
Ardekani, AM ;
Hitt, BA ;
Levine, PJ ;
Fusaro, VA ;
Steinberg, SM ;
Mills, GB ;
Simone, C ;
Fishman, DA ;
Kohn, EC ;
Liotta, LA .
LANCET, 2002, 359 (9306) :572-577